{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:33:46Z","timestamp":1762918426779,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001474","name":"Singapore-MIT Alliance for Research and Technology Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013136","name":"Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Government of Singapore Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.omtn.2024.102444","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T12:04:43Z","timestamp":1735646683000},"page":"102444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extracellular viral microRNAs as biomarkers of virus infection in human cells"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3388-0158","authenticated-orcid":false,"given":"Cheryl","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne Xin Yi","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Xiang","family":"Sin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Bei Lin","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas Kwan Zen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandramouli","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Lorraine Wei Inng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan B.H.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2133-5689","authenticated-orcid":false,"given":"Stacy L.","family":"Springs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102444_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ddtec.2020.08.001","article-title":"Viral safety for biotherapeutics and biosimilar","volume":"37","author":"Ruppach","year":"2020","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.omtn.2024.102444_bib2","first-page":"51074","article-title":"International Conference on Harmonisation; guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability--FDA. Notice","volume":"63","year":"1998","journal-title":"Fed. Regist."},{"key":"10.1016\/j.omtn.2024.102444_bib3","article-title":"Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications","volume":"11","author":"Annaloro","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102444_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41587-020-0507-2","article-title":"Viral contamination in biologic manufacture and implications for emerging therapies","volume":"38","author":"Barone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102444_bib5","first-page":"279","article-title":"Applications of quantitative PCR in the biosafety and genetic stability assessment of biotechnology products","volume":"82","author":"Lovatt","year":"2002","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.omtn.2024.102444_bib6","doi-asserted-by":"crossref","first-page":"380.e1","DOI":"10.1016\/j.cmi.2015.12.012","article-title":"Comparison of respiratory virus shedding by conventional and molecular testing methods in patients with haematological malignancy","volume":"22","author":"Richardson","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.omtn.2024.102444_bib7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.bbmt.2010.11.008","article-title":"Viral Infections in Immunocompromised Patients","volume":"17","author":"Englund","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtn.2024.102444_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.omtn.2024.102444_bib9","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jcyt.2022.05.010","article-title":"Viral infection in hematopoietic stem cell transplantation: an International Society for Cell\u00a0& Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment","volume":"24","author":"Stanojevic","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtn.2024.102444_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/bloodadvances.2017012724","article-title":"Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"2","author":"de Koning","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtn.2024.102444_bib11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/428060","article-title":"Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation","volume":"40","author":"Zerr","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102444_bib12","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1365-2141.2000.02422.x","article-title":"High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients","volume":"111","author":"Ljungman","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omtn.2024.102444_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cid\/cit358","article-title":"Human Herpesvirus 6 (HHV-6) Reactivation and HHV-6 Encephalitis After Allogeneic Hematopoietic Cell Transplantation: A Multicenter, Prospective Study","volume":"57","author":"Ogata","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102444_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/infdis\/142.3.338","article-title":"Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow Transplant","volume":"142","author":"Meyers","year":"1980","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102444_bib15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3389\/fmicb.2019.01186","article-title":"Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients","volume":"10","author":"Stern","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omtn.2024.102444_bib16","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbmt.2014.06.002","article-title":"Varicella-Zoster Reactivation after Allogeneic Stem Cell Transplantation without Routine Prophylaxis\u2014The Incidence Remains High","volume":"20","author":"Blennow","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtn.2024.102444_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/505498","article-title":"Emerging Infections: Adenovirus Infections in Transplant Recipients","volume":"43","author":"Ison","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102444_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijid.2021.09.061","article-title":"Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy","volume":"112","author":"Handley","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102444_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.104740","article-title":"Human herpesvirus 6 and central nervous system disease in oncology patients: A retrospective case series and literature review","volume":"136","author":"Handley","year":"2021","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.omtn.2024.102444_bib20","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1182\/blood-2022-168667","article-title":"Viral Reactivation and Immune Reconstitution after CAR-T Cell Treatment in Patients with Hematologic Malignancies","volume":"140","author":"Kunte","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2024.102444_bib21","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1182\/blood-2022-167908","article-title":"Cytomegalovirus (CMV) Reactivation within in the First Year after Chimeric Antigen Receptor (CAR) T Cell Therapy: Experience from the First Two Years at a Major Cancer Center","volume":"140","author":"Khawaja","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2024.102444_bib22","doi-asserted-by":"crossref","first-page":"851.e1","DOI":"10.1016\/j.jtct.2022.09.007","article-title":"Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy","volume":"28","author":"M\u00e1rquez-Algaba","year":"2022","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.omtn.2024.102444_bib23","doi-asserted-by":"crossref","first-page":"ofab470","DOI":"10.1093\/ofid\/ofab470","article-title":"HHV-6 Encephalitis After Chimeric Antigen Receptor T-cell Therapy (CAR-T): 2 Case Reports and a Brief Review of the Literature","volume":"8","author":"Rebechi","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102444_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1756-8722-6-94","article-title":"Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation","volume":"6","author":"Lin","year":"2013","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.omtn.2024.102444_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11010-012-1261-7","article-title":"Biogenesis of Epstein\u2013Barr virus microRNAs","volume":"365","author":"Kim","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.omtn.2024.102444_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102444_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates microRNA processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102444_bib28","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1126\/science.1073827","article-title":"A microRNA in a Multiple-Turnover RNAi Enzyme Complex","volume":"297","author":"Hutv\u00e1gner","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102444_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.chom.2010.06.014","article-title":"Viral Latency and Its Regulation: Lessons from the \u03b3-Herpesviruses","volume":"8","author":"Speck","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtn.2024.102444_bib30","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1073\/pnas.1422657112","article-title":"Patterns of accumulation of miRNAs encoded by herpes simplex virus during productive infection, latency, and on reactivation","volume":"112","author":"Du","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102444_bib31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.tim.2017.02.002","article-title":"KSHV microRNAs: Tricks of the Devil","volume":"25","author":"Qin","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.omtn.2024.102444_bib32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fcimb.2020.00130","article-title":"Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response","volume":"10","author":"Forte","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.omtn.2024.102444_bib33","doi-asserted-by":"crossref","first-page":"E4991","DOI":"10.1073\/pnas.1419338111","article-title":"Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs","volume":"111","author":"Kalamvoki","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102444_bib34","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1073\/pnas.0914843107","article-title":"Functional delivery of viral miRNAs via exosomes","volume":"107","author":"Pegtel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102444_bib35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10096-019-03747-0","article-title":"Levels of human cytomegalovirus miR-US25-1-5p and miR-UL112-3p in serum extracellular vesicles from infants with HCMV active infection are significantly correlated with liver damage","volume":"39","author":"Zhang","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102444_bib36","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.3390\/ijms23137240","article-title":"BK Polyomavirus bkv-miR-B1-5p: A Stable Micro-RNA to Monitor Active Viral Replication after Kidney Transplantation","volume":"23","author":"Demey","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.omtn.2024.102444_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ebiom.2017.04.018","article-title":"Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections","volume":"20","author":"Fuentes-Mattei","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2024.102444_bib38","series-title":"Encyclopedia of Virology","first-page":"29","article-title":"Diagnostic Techniques: Serological and Molecular Approaches","author":"Vainionp\u00e4\u00e4","year":"2008"},{"key":"10.1016\/j.omtn.2024.102444_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpha.2019.05.004","article-title":"Research advances in the detection of miRNA","volume":"9","author":"Ye","year":"2019","journal-title":"J.\u00a0Pharm. Anal."},{"key":"10.1016\/j.omtn.2024.102444_bib40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2144\/btn-2019-0021","article-title":"Evaluation of miRNA detection methods for the analytical characteristic necessary for clinical utilization","volume":"66","author":"Krepelkova","year":"2019","journal-title":"Biotechniques"},{"key":"10.1016\/j.omtn.2024.102444_bib41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3892\/ijmm.2017.3080","article-title":"Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum","volume":"40","author":"Tang","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.omtn.2024.102444_bib42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41598-020-57497-7","article-title":"A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum","volume":"10","author":"Brennan","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102444_bib55","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1128\/JVI.03001-14","article-title":"Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines","volume":"89","author":"Coleman","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102444_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nmeth746","article-title":"Identification of microRNAs of the herpesvirus family","volume":"2","author":"Pfeffer","year":"2005","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2024.102444_bib44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/JVI.02013-09","article-title":"In-Depth Analysis of Kaposi\u2019s Sarcoma-Associated Herpesvirus MicroRNA Expression Provides Insights into the Mammalian MicroRNA-Processing Machinery","volume":"84","author":"Umbach","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102444_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.virol.2009.01.006","article-title":"The microRNAs of Epstein\u2013Barr Virus are expressed at dramatically differing levels among cell lines","volume":"386","author":"Pratt","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2024.102444_bib46","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/jvi.71.1.314-324.1997","article-title":"Selective switch between latency and lytic replication of Kaposi\u2019s sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells","volume":"71","author":"Miller","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102444_bib47","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.chom.2008.10.007","article-title":"A Highly Structured, Nuclease-Resistant, Noncoding RNA Produced by Flaviviruses Is Required for Pathogenicity","volume":"4","author":"Pijlman","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtn.2024.102444_bib48","doi-asserted-by":"crossref","first-page":"E587","DOI":"10.1073\/pnas.1518130113","article-title":"Sensing of latent EBV infection through exosomal transfer of 5\u2032pppRNA","volume":"113","author":"Baglio","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102444_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01698-16","article-title":"Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi\u2019s Sarcoma-Associated Herpesvirus","volume":"91","author":"Schifano","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102444_bib50","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fimmu.2017.01182","article-title":"The Clinical Application of MicroRNAs in Infectious Disease","volume":"8","author":"Drury","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102444_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-44743-w","article-title":"Extracellular vesicles from T\u00a0cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation","volume":"9","author":"Balducci","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102444_bib52","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/0004563215604001","article-title":"microRNA expression in blood of dengue patients","volume":"53","author":"Tambyah","year":"2016","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.omtn.2024.102444_bib53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41467-023-44648-3","article-title":"Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102444_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00027-20","article-title":"Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients","volume":"33","author":"Zanella","year":"2020","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124003317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124003317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:24:09Z","timestamp":1762601049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124003317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2162253124003317"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102444","relation":{},"ISSN":["2162-2531"],"issn-type":[{"type":"print","value":"2162-2531"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular viral microRNAs as biomarkers of virus infection in human cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102444"}}